The Patent Finder

Alltranz Inc.

Also on record
Records under this name other than patents Alltranz Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Alltranz Inc.

PatentTitleStatus Expires Confidence
US 7,511,054Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,309,568Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,695,143Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,957,246Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,980,942Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Formerly held
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 8,293,786Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,227,627Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,449,908Transdermal Delivery of Cannabidiol
Formerly held
Term ended
Term ended Mar 16, 2026 · Medium confidence
Term endedTerm ended Mar 16, 2026Medium confidence
US 8,481,560Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
Formerly held
Lapsed on the fee record
Ended Jul 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2025From the USPTO record
US 8,435,556Transdermal Delivery of Cannabidiol
Term ended
Term ended Jun 24, 2023 · Medium confidence
Term endedTerm ended Jun 24, 2023Medium confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited